TCR-JANUS engager proteins enable bispecific targeting to overcome tumor heterogeneity in TCR-T cell therapy.

Cheng C, Liang T, Yao P, Wang W, Chen H, Li X, Tian Y, Wang J, Yan N, Xie D, Qiu F, Tan S

DOI: 10.1126/sciadv.aed9825
Published: 2026 Sep 11
Container: Science advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1126/sciadv.aed9825,
  title = {TCR-JANUS engager proteins enable bispecific targeting to overcome tumor heterogeneity in TCR-T cell therapy.},
  author = {Cheng C and Liang T and Yao P and Wang W and Chen H and Li X and Tian Y and Wang J and Yan N and Xie D and Qiu F and Tan S},
  year = {2026},
  journal = {Science advances},
  doi = {10.1126/sciadv.aed9825},
  url = {https://doi.org/10.1126/sciadv.aed9825}
}

RIS

TY  - JOUR
TI  - TCR-JANUS engager proteins enable bispecific targeting to overcome tumor heterogeneity in TCR-T cell therapy.
AU  - Cheng C
AU  - Liang T
AU  - Yao P
AU  - Wang W
AU  - Chen H
AU  - Li X
AU  - Tian Y
AU  - Wang J
AU  - Yan N
AU  - Xie D
AU  - Qiu F
AU  - Tan S
PY  - 2026
JO  - Science advances
DO  - 10.1126/sciadv.aed9825
UR  - https://doi.org/10.1126/sciadv.aed9825
ER  -

APA

C, C., T, L., P, Y., W, W., H, C., X, L., Y, T., J, W., N, Y., D, X., F, Q., & S, T. (2026). TCR-JANUS engager proteins enable bispecific targeting to overcome tumor heterogeneity in TCR-T cell therapy.. Science advances. https://doi.org/10.1126/sciadv.aed9825

Source records

pubmed · retrieved 2026-09-25T00:45:44.332Z